Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Depei Wu

Showing results (21-30 of 579) with videos related to

Pageof 58
Sort By:
Journal of Affective Disorders|March 13, 2024
Different dosage regimens of zuranolone in the treatment of major depressive disorder: A meta-analysis of randomized controlled trialsJinrong Lian, Zhimin Lin, Xiang Li, et al.
Journal of Immunology Research|June 20, 2015
The Role of Intestinal Microbiota in Acute Graft-versus-Host DiseaseYuanyuan Chen, Ye Zhao, Qiao Cheng, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 28, 2023
Master kinase PDK1 in tumorigenesisNana Zheng, Jiaqi Wei, Depei Wu, et al.
Leukemia Research|October 4, 2015
Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemiaQi Qu, Limin Liu, Yanming Zhang, et al.
Frontiers in Immunology|September 4, 2024
Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphomaXiangping Zong, Zhen Yang, Jin Zhou, et al.
Thrombosis Journal|May 31, 2025
Unveiling the role of lipid metabolism in haemorrhagic disorders: genetic insights and therapeutic perspectivesJiaqi Wei, Zhen Yang, Xiaojin Wu, et al.
Biochemical and Biophysical Research Communications|April 19, 2016
miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3Yinghao Lu, Depei Wu, Jishi Wang, et al.
European Journal of Haematology|August 19, 2011
Functional genetic variations of cyclooxygenase-2 and susceptibility to acute myeloid leukemia in a Chinese populationJian Zheng, Suning Chen, Lan Jiang, et al.
Journal of Translational Medicine|June 19, 2026
Deciphering elevated risk of life-threatening hemorrhage and early death in acute myeloid leukemia with APL-like phenotype: independent role of endothelial injury and implications of EASIX-based risk stratification in a multicenter studyMingkai Shu, Xiaoli Li, Yun Wang, et al.
Leukemia Research|December 7, 2010
Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21)Ying Wang, Weiyang Li, Suning Chen, et al.
Pageof 58

Showing results (21-30 of 579) with videos related to

Sort By:
Pageof 58
Journal of Affective Disorders|March 13, 2024
Different dosage regimens of zuranolone in the treatment of major depressive disorder: A meta-analysis of randomized controlled trialsJinrong Lian, Zhimin Lin, Xiang Li, et al.
Journal of Immunology Research|June 20, 2015
The Role of Intestinal Microbiota in Acute Graft-versus-Host DiseaseYuanyuan Chen, Ye Zhao, Qiao Cheng, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 28, 2023
Master kinase PDK1 in tumorigenesisNana Zheng, Jiaqi Wei, Depei Wu, et al.
Leukemia Research|October 4, 2015
Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemiaQi Qu, Limin Liu, Yanming Zhang, et al.
Frontiers in Immunology|September 4, 2024
Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphomaXiangping Zong, Zhen Yang, Jin Zhou, et al.
Thrombosis Journal|May 31, 2025
Unveiling the role of lipid metabolism in haemorrhagic disorders: genetic insights and therapeutic perspectivesJiaqi Wei, Zhen Yang, Xiaojin Wu, et al.
Biochemical and Biophysical Research Communications|April 19, 2016
miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3Yinghao Lu, Depei Wu, Jishi Wang, et al.
European Journal of Haematology|August 19, 2011
Functional genetic variations of cyclooxygenase-2 and susceptibility to acute myeloid leukemia in a Chinese populationJian Zheng, Suning Chen, Lan Jiang, et al.
Journal of Translational Medicine|June 19, 2026
Deciphering elevated risk of life-threatening hemorrhage and early death in acute myeloid leukemia with APL-like phenotype: independent role of endothelial injury and implications of EASIX-based risk stratification in a multicenter studyMingkai Shu, Xiaoli Li, Yun Wang, et al.
Leukemia Research|December 7, 2010
Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21)Ying Wang, Weiyang Li, Suning Chen, et al.
Pageof 58